
THE SHROOMVERSE JOURNAL ✳ 15 MIN READ
Why do magic mushrooms cause nausea, yawning and dilated pupils? What studies record
Topic: Safety and risk
Published Updated
Listen: the 3-minute version
AI-narrated summary of this article
Short answer, checked 19 October 2026
Psilocin, the form of psilocybin the body uses, acts on serotonin receptors in the brain and body, and that is thought to drive the physical effects as well as the mental ones. In a 2024 review of clinical studies, about a quarter of psilocybin participants reported nausea, about one in twenty vomiting, and about one in nine yawning. Lab studies measure wider pupils and modest rises in blood pressure, heart rate and temperature. Yawning in particular has barely been studied. Severe or delayed vomiting and diarrhea, chest pain, seizures, rigid muscles or a very high temperature are not normal effects: call 911 or a poison centre.
On this page 10 sections
People who have taken magic mushrooms often describe feeling them in the body before anything else: an unsettled stomach, yawning, a chill, a pounding heart. Searches like “do shrooms dilate pupils” and “why do shrooms make you yawn” are common. This guide explains what is known about why these body effects happen, how often controlled studies have recorded each one, and where the science simply has no answer yet.
It also covers the point that matters most for safety: some body symptoms are not a normal effect of psilocybin at all. They can be a sign of a poisonous mushroom, a dangerous drug interaction or a heart problem.
General information, not medical advice
This article describes published research. It gives no doses, no preparation tips and no advice on managing symptoms. The figures come mostly from screened volunteers given measured psilocybin under supervision, which is very different from mushrooms found or bought outside a study. Our safety page keeps Canadian emergency numbers.
Why do magic mushrooms have body effects at all?
Magic mushrooms contain psilocybin, which the body converts into psilocin, the active form (we explain the difference in psilocin vs psilocybin). Psilocin acts on serotonin receptors, especially the serotonin 2A receptor. A brain-imaging study in eight healthy volunteers found that psilocybin occupied up to 72% of these receptors, and that how intense people rated the experience tracked both receptor occupancy and blood levels of psilocin (Madsen et al., 2019). Evidence: established for the mental effects; that study did not measure body symptoms.
Psychedelics do more than change perception. A 2022 review describes the body effects of psychedelics as “sympathomimetic”, meaning they resemble the body’s fight-or-flight response: rises in heart rate, blood pressure, pupil size and body temperature that it calls short-lived and not clinically significant in the studies it reviewed (Schlag et al., 2022).
The clearest evidence that the 2A receptor drives some body effects comes from LSD, not psilocybin. In a randomized, placebo-controlled crossover study of 24 healthy volunteers, ketanserin, a drug that blocks the 2A receptor, given after LSD reversed LSD-induced pupil dilation, reduced the overall rise in blood pressure and reduced nausea ratings over the session (Becker et al., 2023). That is consistent with the idea, but we found no equivalent study measuring body symptoms after psilocybin. Evidence: preliminary for psilocybin.
Why do shrooms cause nausea and vomiting?
Nausea is one of the most consistently recorded effects. A 2024 systematic review and meta-analysis pooled adverse events from clinical and research studies of classic psychedelics. For psilocybin, nausea was reported by 24.2% of participants (25 study groups, 718 people), vomiting by 4.8% (9 groups, 271 people) and abdominal discomfort by 7.6% (Hinkle et al., 2024). The review pooled effects during the experience with those in the following two days, and its authors say the findings cannot be generalized to unsupervised use outside clinical settings.
Placebo-controlled trials confirm that this is the drug, not just nerves. A 2024 meta-analysis of six randomized, double-blind trials in 528 people treated for depression or anxiety found nausea was about 8.9 times as likely after psilocybin as after a comparison treatment (relative risk 8.85). Headache, anxiety, dizziness and raised blood pressure were also more likely, and the authors report that the acute adverse effects resolved within 48 hours (Yerubandi et al., 2024). Evidence: established that nausea is common in trials.
Why it happens is less settled. Health Canada describes dry mouth, sometimes leading to nausea and vomiting (Health Canada). Serotonin receptor activity is a likely part of it, given the LSD and ketanserin result above, and researchers who analysed mushroom experience reports note that the early nausea and restlessness resemble an acute stress reaction (Brouwer et al., 2025). Whole mushrooms also contain other material besides psilocybin, and no study we found has separated the role of each. Evidence: unresolved.
Timing matters for understanding the experience. In a qualitative study of 2,343 psilocybin mushroom reports on Erowid, the researchers coded 47 descriptions of the “come-up” and found nausea in 34% of them, the most common theme. The come-down was more often described in positive terms (Brouwer et al., 2025). These are self-selected online accounts, and the authors say their method cannot show what percentage of all users feel nausea.
Do shrooms dilate pupils?
Yes. Dilated pupils (mydriasis) are among the physical signs listed in safety guidelines for human hallucinogen research (Johnson et al., 2008), and they have been measured. In a randomized, double-blind, placebo-controlled crossover study of 32 healthy participants, psilocybin, LSD and mescaline each increased pupil size compared with placebo, with no difference between the three. The authors describe the autonomic effects as moderate, transient and not a safety concern in that setting (Ley et al., 2023).

Wider pupils are part of the fight-or-flight-like pattern described above (Schlag et al., 2022). In the LSD study, blocking the 2A receptor reversed the pupil dilation (Becker et al., 2023). The 2024 review did not have enough psilocybin studies reporting mydriasis to pool them; for LSD it estimated 72.6% (Hinkle et al., 2024). A review of mushroom poisonings also lists mydriasis among reported signs after hallucinogenic mushrooms (Graeme, 2014).
Evidence: established that psilocybin enlarges pupils; how much it varies between people is not well described.
Why do shrooms make you yawn?
Honestly, nobody has studied this properly. Yawning shows up in the data: the 2024 review estimated it in 11.4% of psilocybin participants, but only three study groups (94 people) reported it, and the confidence interval runs from 3.3% to 32.6% (Hinkle et al., 2024). Yawning, feeling cold and sweating are also mentioned in mushroom experience reports describing the come-up (Brouwer et al., 2025). We found no study designed to explain yawning after psilocybin.
What is known is general. A 2025 review of yawning says it is started mainly by the hypothalamus and brainstem, with dopamine, serotonin and oxytocin playing roles, and that agonists of serotonin 2 receptors induced yawning in several studies (Wani and Agarwal, 2025). Other serotonin drugs cause yawning too: in a prospective study of 110 patients starting an SSRI antidepressant, excessive yawning rose from 5.4% to 15.4% after a month (Yıldırım et al., 2026).
Putting those together, it is plausible that psilocin’s action on serotonin receptors triggers yawning, but that is an inference, not a finding. In the experience reports, yawning appears in descriptions of the come-up rather than the end of the experience. Evidence: unresolved.
Why do magic mushrooms cause chills, a faster heartbeat and higher blood pressure?
Health Canada lists increased heart rate and blood pressure, and sweating and high body temperature, often followed by chills and shivering (Health Canada). In the controlled crossover study, psilocybin moderately raised systolic and diastolic blood pressure, heart rate and body temperature compared with placebo; psilocybin raised diastolic pressure more than LSD did (Ley et al., 2023). The 2024 review estimated “hypertension” as an adverse event in 19.1% of psilocybin participants, a fast heart rate in 8.9% and feeling cold in 6.1%, each from small numbers of studies (Hinkle et al., 2024).

Tolerance is relevant here. The 2022 review notes that tolerance builds quickly to the psychedelic effects but has been reported not to build to autonomic effects such as pupil dilation, raised blood pressure, raised body temperature, goosebumps and a fast heart rate (Schlag et al., 2022).
“Not clinically significant” applies to screened, healthy volunteers. Health Canada says that for people with heart disease, the rise in blood pressure and heart rate could be harmful (Health Canada). Research guidelines also note that hallucinogens can moderately raise pulse and both systolic and diastolic blood pressure (Johnson et al., 2008). Evidence: established for healthy volunteers; the risk for people with heart conditions is flagged, not measured.
Why do shrooms make you sleepy or tired afterwards?
Tiredness is common in the data. The 2024 review estimated fatigue or weakness in 26.6% of psilocybin participants and sleepiness (somnolence) in 12.6% (Hinkle et al., 2024). Health Canada lists muscle weakness among short-term effects (Health Canada), and mushroom experience reports mention heaviness and lethargy (Brouwer et al., 2025).
The mechanism is not established, and no study we found has tested a cause. One research group notes that psychedelics have been shown to trigger the release of stress hormones, and compares the come-up to an acute stress reaction (Brouwer et al., 2025), but that is a description, not an explanation of later tiredness. In the controlled crossover study, psilocybin did not produce significant adverse effects in the 12 to 24 hours after dosing compared with placebo (Ley et al., 2023), and the trial meta-analysis reports acute effects resolving within 48 hours (Yerubandi et al., 2024). Our guide to how long magic mushrooms last covers timing and after-effects in more detail. Evidence: established that tiredness is commonly reported; the cause is unresolved.
Magic mushroom body effects at a glance
| Effect | How often recorded (psilocybin) | Likely mechanism | Evidence |
|---|---|---|---|
| Nausea | 24.2% (25 groups, 718 people); about 8.9 times as likely as with a comparator in six RCTs | Serotonin receptor activity likely; not settled | Established that it is common |
| Vomiting | 4.8% (9 groups, 271 people) | As for nausea | Established, fewer data |
| Dilated pupils | Measured in a placebo-controlled study; too few psilocybin studies to pool a rate | Fight-or-flight pattern; 2A receptor in an LSD study | Established |
| Yawning | 11.4% (3 groups, 94 people; wide uncertainty) | Serotonin plausible; not studied | Unresolved |
| Feeling cold, chills | 6.1% feeling cold (3 groups, 90 people) | Temperature rise then chills, per Health Canada | Preliminary |
| Raised blood pressure | 19.1% as an adverse event (12 groups, 302 people) | Fight-or-flight pattern | Established, modest in healthy volunteers |
| Fast heart rate | 8.9% (4 groups, 68 people) | Fight-or-flight pattern | Established, modest in healthy volunteers |
| Fatigue or weakness | 26.6% (17 groups, 581 people) | Not established | Established that it is common |
Rates in the table are from the 2024 review, except where a randomized trial is named (Hinkle et al., 2024; Yerubandi et al., 2024; Ley et al., 2023). The review notes that only 16 of 68 recent studies described a systematic way of collecting adverse events, so true rates could differ. For the mental effects, see magic mushroom effects, short and long term.
When are body symptoms a warning sign rather than a normal effect?
Call 911 or a poison centre
If the person is unconscious, not breathing or having a seizure, call 911 (CAPCC). For a possible poisoning, call a poison centre without waiting for symptoms. Health Canada’s national number, 1-844-POISON-X (1-844-764-7669), routes callers to their local poison centre; Quebec uses its own line, 1-800-463-5060 (Health Canada). The Ontario Poison Centre answers 24 hours a day on 1-800-268-9017 (Ontario Poison Centre). In Nunavut, the CAPCC says to contact your local health centre (CAPCC). Numbers checked 19 October 2026.
Vomiting and diarrhea that start hours later
Nausea from psilocybin tends to come early, during the come-up. Gut symptoms that begin many hours after eating a mushroom are a different matter. A medical review of mushroom poisoning notes that people looking for hallucinogenic mushrooms sometimes misidentify and eat more toxic ones, which can cause delayed symptoms and possibly organ failure. For amatoxin mushrooms, it describes a symptom-free period typically of 6 to 24 hours (reported up to 40 hours), then vomiting, watery diarrhea and abdominal pain, then an apparent recovery while liver damage continues (Graeme, 2014).
The Ontario Poison Centre says you may not become ill for many hours after eating a poisonous mushroom and not to wait until the person feels sick before calling (Ontario Poison Centre). Health Canada warns that many species look alike and that people can eat poisonous mushrooms by mistake (Health Canada). We cover this in magic mushroom misidentification and poisonous mushrooms in Ontario.
Signs of serotonin syndrome with some medicines
Serotonin syndrome is a drug-induced condition caused by too much serotonin activity, usually from drug interactions. Mild cases bring tremor and diarrhea; severe cases can bring delirium, rigid muscles, seizures, coma and very high body temperature. A 2025 scoping review of 18 studies found no increased risk of serotonin syndrome with antidepressants and psilocybin in those studies, but much of the evidence was case reports, surveys and open-label studies (Tap et al., 2025). Our guide to magic mushrooms and antidepressants covers what is known by medicine type. Do not stop or change a medicine on your own; ask a prescriber or pharmacist.
Chest pain, a pounding heart or a severe headache
A modest rise in heart rate is expected; chest pain is not. One case report describes a man taking the antidepressant tranylcypromine (an MAOI) and an amphetamine medicine who, about half an hour after eating psilocybin mushrooms, developed severe high blood pressure with chest pain, palpitations and headache. He was first diagnosed with a heart attack, though catheterization found no significant abnormality, and he went home without lasting harm. The authors suspect, without testing it, that another mushroom compound interacted with his medicines (Barnett et al., 2025). The poisoning review lists dysrhythmias and heart attack among reported events after hallucinogenic mushrooms (Graeme, 2014). These are rare reports, but chest pain, fainting or a severe headache warrant a 911 call.
Anxiety can feel physical too: the experience-report study notes that anxiety, attention to heartbeat and breathing, and nausea are common in stress reactions (Brouwer et al., 2025). If someone is in emotional crisis or thinking about suicide, the Government of Canada says to call or text 9-8-8, 24 hours a day (Government of Canada). Our guide to whether magic mushrooms are safe puts these risks in a wider frame.
What we still don’t know
- Exactly which receptors cause nausea after psilocybin, and whether other compounds in whole mushrooms add to it (unresolved).
- Why psilocybin causes yawning. Only three study groups reported it and no study has tested a mechanism (unresolved).
- How common each body effect is with mushrooms used outside studies, where amounts and contents are unknown (unresolved).
- What the heart effects mean for people with heart disease or high blood pressure, who are excluded from most trials (flagged by Health Canada, not measured).
- Why people feel tired afterwards, and how long it lasts outside trial settings (unresolved).
Research moves quickly, so check the date at the top of this page. For background, see what magic mushrooms are.
Common questions
Why do shrooms make you nauseous?
Psilocin’s action on serotonin receptors is the likely reason, but the exact mechanism is not settled. Nausea is common: a 2024 review found it in 24.2% of psilocybin participants in clinical studies, and in randomized trials it was about 8.9 times as likely as with a comparator.
Do shrooms dilate your pupils?
Yes. A placebo-controlled study of 32 healthy volunteers measured larger pupils after psilocybin, similar to LSD and mescaline. Pupil dilation is part of the fight-or-flight-like body response psychedelics produce, and it is short-lived.
Why do shrooms make you yawn?
Nobody knows for certain. Yawning was recorded in about 11% of psilocybin participants across three study groups, and serotonin is known to play a role in yawning, but no study has tested why psilocybin causes it.
Why do shrooms make you sleepy or tired?
The cause has not been established. Fatigue or weakness was recorded in 26.6% of psilocybin participants and sleepiness in 12.6% in a 2024 review. In randomized trials, acute adverse effects resolved within 48 hours.
Why do magic mushrooms give you chills?
Health Canada says sweating and high body temperature are often followed by chills and shivering. Controlled studies measured a modest rise in body temperature after psilocybin. Feeling cold was recorded in about 6% of psilocybin participants.
When is vomiting after mushrooms an emergency?
Vomiting, diarrhea or stomach pain that starts many hours after eating a wild or unidentified mushroom can be a sign of poisoning by a toxic look-alike. Call a poison centre right away (1-844-764-7669, or 1-800-463-5060 in Quebec) even if the person feels fine, and 911 if they are unconscious, not breathing or having a seizure.
Is chest pain after shrooms normal?
No. A modest rise in heart rate and blood pressure is recorded in studies, but chest pain is not a normal effect. Case reports describe severe high blood pressure and heart problems, including with certain medicines. Call 911.
Shroomverse sells mushroom products. This article is general information about the physical effects recorded in research. It is not medical, legal or purchasing advice, and it does not recommend any product.
SOURCES
- Psilocybin and psilocin (magic mushrooms), Health Canada. Accessed . Page details show 2026-10-20; re-read 24 October 2026. Source for the listed short-term physical effects (raised heart rate and blood pressure; dry mouth sometimes leading to nausea and vomiting; muscle weakness; sweating and high body temperature often followed by chills and shivering), the heart-disease warning and the look-alike warning.
- Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis (Hinkle JT, Graziosi M, Nayak SM, Yaden DB, JAMA Psychiatry 81(12):1225–1235, 2024), American Medical Association (peer-reviewed); full text via PubMed Central, PMC11375525. Accessed . Full text consulted (Table 2). Source for psilocybin event rates: nausea 24.2%, vomiting 4.8%, abdominal discomfort 7.6%, yawning 11.4% (3 groups, 94; CI 3.3–32.6%), feeling cold 6.1%, hypertension 19.1%, tachycardia 8.9%, fatigue or weakness 26.6%, somnolence 12.6%; LSD mydriasis 72.6%; pooling of acute and subacute (to 48 h) events; 16 of 68 recent studies with systematic AE assessment; limit on generalizing to unsupervised use.
- Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis (Yerubandi A, Thomas JE, Bhuiya NMMA, et al., JAMA Network Open 7(4):e245960, 2024), American Medical Association (peer-reviewed, open access); PMC11007582. Accessed . Abstract consulted. Source for six randomized double-blind trials, 528 participants, nausea relative risk 8.85, higher risk of headache, anxiety, dizziness and raised blood pressure, and resolution within 48 hours.
- Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants (Ley L, Holze F, Arikci D, et al., Neuropsychopharmacology 48(11):1659–1667, 2023), Springer Nature (peer-reviewed, open access); full text via PubMed Central, PMC10517157. Accessed . Full text consulted. Source for 32 healthy participants; psilocybin moderately raising blood pressure, heart rate, body temperature and pupil size versus placebo; higher diastolic response than LSD; effects described as moderate, transient and not a safety concern; no significant 12–24 h adverse effects for psilocybin versus placebo.
- Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants (Becker AM, Klaiber A, Holze F, et al., International Journal of Neuropsychopharmacology 26(2):97–106, 2023), Oxford University Press (peer-reviewed, open access); full text via PubMed Central, PMC9926053. Accessed . Abstract and full text consulted. LSD study, not psilocybin: 24 healthy participants; ketanserin reversed LSD-induced mydriasis, reduced overall blood-pressure elevation and reduced nausea ratings (area under the effect curve).
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (Madsen MK, Fisher PM, Burmester D, et al., Neuropsychopharmacology 44(7):1328–1334, 2019), Springer Nature (peer-reviewed); PMC6785028. Accessed . Abstract consulted. Source for eight healthy volunteers, receptor occupancy up to 72%, and intensity tracking occupancy and plasma psilocin.
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science (Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ, Journal of Psychopharmacology 36(3):258–272, 2022), SAGE (peer-reviewed, open access); full text via PubMed Central, PMC8905125. Accessed . Full text consulted. Source for short-lived, non-clinically significant sympathomimetic effects on heart rate, blood pressure, pupil size and temperature, and for tolerance not developing to autonomic effects.
- Human hallucinogen research: guidelines for safety (Johnson MW, Richards WA, Griffiths RR, Journal of Psychopharmacology 22(6):603–620, 2008), SAGE (peer-reviewed); author manuscript via PubMed Central, PMC3056407. Accessed . Full text consulted. Source for physical signs including nausea, drowsiness and dilated pupils, and for moderate rises in pulse and blood pressure.
- A qualitative analysis of the psychedelic mushroom come-up and come-down (Brouwer A, Brown JK, Erowid E, et al., npj Mental Health Research 4:6, 2025), Springer Nature (peer-reviewed, open access); full text via PubMed Central, PMC11802880. Accessed . Full text consulted. Source for 2,343 Erowid reports, 47 coded come-up descriptions with nausea in 34%, yawning, feeling cold and sweating in come-up accounts, lethargy, the stress-reaction comparison, and the authors’ limitation that prevalence cannot be estimated.
- The science of yawning: Exploring its physiology, evolutionary role, and behavioral impact (Wani PD, Agarwal M, Journal of Family Medicine and Primary Care 14(8):3115–3120, 2025), Wolters Kluwer Medknow (open access); full text via PubMed Central, PMC12488162. Accessed . Full text consulted. General review; source for hypothalamus and brainstem control of yawning, the roles of dopamine, serotonin and oxytocin, and serotonin 2 receptor agonists inducing yawning in studies.
- Prevalence of SSRI-Related yawning and relationship with clinical features in patients with major depressive disorder: A prospective study (Yıldırım YE, Yurtseven E, Aydın PÇ, Günver MG, Journal of Psychiatric Research 192:378–384, 2026), Elsevier (peer-reviewed); record on PubMed, PMID 41197220. Accessed . Abstract consulted. Source for 110 patients completing follow-up and excessive yawning rising from 5.4% to 15.4% after starting an SSRI. Cited only to show serotonin drugs can cause yawning.
- Mycetism: a review of the recent literature (Graeme KA, Journal of Medical Toxicology 10(2):173–189, 2014), Springer (peer-reviewed); full text via PubMed Central, PMC4057534. Accessed . Full text consulted. Source for misidentification by people seeking hallucinogenic mushrooms causing delayed symptoms, the amatoxin 6–24 h latency (up to 40 h), the gastroenteritis and remission phases, and reported mydriasis, hypertension, tachycardia, dysrhythmias and myocardial infarction after hallucinogenic mushrooms.
- Concomitant use of antidepressants and classic psychedelics: A scoping review (Tap SC, Thomas K, Páleníček T, et al., Journal of Psychopharmacology 39(10):1072–1088, 2025), SAGE (peer-reviewed, open access); full text via PubMed Central, PMC12572353. Accessed . Full text consulted. Source for the description of serotonin syndrome, 18 included studies, no increased serotonin-syndrome risk found, and the evidence-quality caveat.
- Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine (Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA, Journal of Psychoactive Drugs 57(3):297–303, 2025), Taylor & Francis (peer-reviewed); record on PubMed, PMID 38903003. Accessed . Abstract consulted. Single case report: chest pain, palpitations and headache with severe hypertension about half an hour after mushrooms; no significant cardiac abnormality on catheterization; the authors’ untested suspicion about another mushroom compound.
- Mushrooms, Ontario Poison Centre. Accessed . Source for illness possibly starting many hours after a poisonous mushroom, calling right away without waiting for symptoms, and 1-800-268-9017, 24 hours a day, every day of the year.
- Canadian Association of Poison Centres and Clinical Toxicology (home page), CAPCC. Accessed . Source for calling 911 if the person is unconscious, not breathing or having a seizure; 1-844-POISON-X (1-844-764-7669); Quebec 1-800-463-5060; Nunavut, contact the local health centre.
- Canada launches new toll-free 1-844 POISON-X number for poison centres, Health Canada (news release, 20 March 2023). Accessed . Source for 1-844-764-7669 routing callers to their local poison centre and Quebec keeping 1-800-463-5060.
- Mental health: get help, Government of Canada, Public Health Agency of Canada. Accessed . Source for calling or texting 9-8-8 (24/7) and 9-1-1 for immediate danger or urgent medical support.
CHANGES
- : Published.
- : Re-read Health Canada’s psilocybin page, updated on 20 October 2026, and corrected its date here. The statements this article cites from it are unchanged.



